Ad-hoc | 7 January 2014 11:11


Carl Zeiss Meditec expects Q1 revenues to slightly decline from the previous year’s level

Carl Zeiss Meditec AG  / Key word(s): Development of Sales

07.01.2014 11:11

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------



Carl Zeiss Meditec expects Q1 revenues to slightly decline from the
previous year's level

Jena, January 7, 2014: Carl Zeiss Meditec AG (ISIN: DE0005313704) expects
Q1 2013/14 revenues to decline slightly from the previous year's level (Q1
2012/2013: EUR 219 million). On preliminary data, reported revenue is
likely to have declined by around 3% vs. Q1 2012/13. The decline is mainly
related to negative currency effects. On a constant currency basis, revenue
growth has been slightly positive. Q1 2013/14 EBIT is expected below the
previous year's Q1.


Contact for investors Sebastian Frericks, Director Investor Relations, Carl Zeiss Meditec AG Tel. +49 3641 220-116, E-Mail: investors.meditec@zeiss.com Press contact Jann Gerrit Ohlendorf, Director Corporate Communications, Carl Zeiss Meditec AG Tel. +49 3641 220-331, E-Mail: press.meditec@zeiss.com 07.01.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Carl Zeiss Meditec AG Göschwitzer Str. 51-52 07745 Jena Germany Phone: +49 (0)3641 220-0 Fax: +49 (0)3641 220-112 E-mail: investors.meditec@zeiss.com,info.meditec@zeiss.com Internet: www.meditec.zeiss.de ISIN: DE0005313704 WKN: 531370 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------